Charles Schwab’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$75.7K Sell
2025
Q1
$226K Sell
2024
Q4
$685K Sell
2024
Q3
$814K Sell
2024
Q2
$835K Buy
2024
Q1
$553K Buy
2023
Q4
$337K Buy
2023
Q3
$647K Buy
2023
Q2
$790K Buy
2023
Q1
$739K Buy